Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction

Table 1 Comparison of blood lipid indexes, platelet maximum aggregation rate, and plasma viscosity between the two groups (mean ± SD)

Group		Control group (n = 41)	Observation group (n = 41)
TC (mmol/L)	Before treatment	6.52 ± 0.47	6.40 ± 0.56
	After treatment	5.17 ± 0.41a	4.79 ± 0.32a,c
TG (mmol/L)	Before treatment	2.92 ± 0.41	2.89 ± 0.45
	After treatment	2.05 ± 0.36 a	1.68 ± 0.31a,c
HDL-C (mmol/L)	Before treatment	0.96 ± 0.31	0.95 ± 0.36
	After treatment	1.67 ± 0.37a	1.95 ± 0.42a,c
LDL-C (mmol/L)	Before treatment	4.25 ± 0.56	4.21 ± 0.53
	After treatment	3.37 ± 0.45a	2.89 ± 0.39a,c
Maximum platelet aggregation rate(%)	Before treatment	75.92 ± 9.64	78.40 ± 10.22
	After treatment	46.48 ± 7.26a	58.30 ± 7.74a,c
Blood plasma viscosity (mPa·s)	Before treatment	1.86 ± 0.48	1.94 ± 0.43
	After treatment	1.40 ± 0.33a	1.61 ± 0.35a,c

^aP < 0.05 vs before treatment.

^cP < 0.05 vs the control group.

TC: Total cholesterol; HDL-C: High density lipoprotein cholesterol; LDL-C: Low density lipoprotein cholesterol.